PUBLISHER: 360iResearch | PRODUCT CODE: 1318710

PUBLISHER: 360iResearch | PRODUCT CODE: 1318710

Pharmerging Market by Product (OTC Drugs, Pharmaceuticals), Indication (Cancer & Autoimmune Diseases, Lifestyle Diseases), Distribution - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

PUBLISHED: June 12, 2023

PAGES: 191 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

List of Tables

The Global Pharmerging Market is forecasted to grow significantly, with a projected USD 1,537.84 million in 2023 at a CAGR of 9.67% and expected to reach a staggering USD 2,948.21 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Pharmerging Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Pharmerging Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across OTC Drugs and Pharmaceuticals. The Pharmaceuticals is further studied across Branded Prescription Drugs and Generic Drugs. The Pharmaceuticals is projected to witness significant market share during forecast period.

Based on Indication, market is studied across Cancer & Autoimmune Diseases and Lifestyle Diseases. The Cancer & Autoimmune Diseases is projected to witness significant market share during forecast period.

Based on Distribution, market is studied across Clinics, Drug Stores, E-Commerce, and Hospitals. The Clinics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Pharmerging Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Pharmerging Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmerging Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmerging Market?

4. What is the competitive strategic window for opportunities in the Global Pharmerging Market?

5. What are the technology trends and regulatory frameworks in the Global Pharmerging Market?

6. What is the market share of the leading vendors in the Global Pharmerging Market?

7. What modes and strategic moves are considered suitable for entering the Global Pharmerging Market?

Product Code: MRR-030EE4851607

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Pharmerging Market, by Product, 2022 vs 2030
4.3. Pharmerging Market, by Indication, 2022 vs 2030
4.4. Pharmerging Market, by Distribution, 2022 vs 2030
4.5. Pharmerging Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing elderly population and rising burden of chronic diseases worldwide
  - 5.1.1.2. Rising number of private hospitals and healthcare institutes
  - 5.1.1.3. Extensive spending on healthcare globally and growing life expectancy among people
- 5.1.2. Restraints
  - 5.1.2.1. High cost of research and development and strict price control
- 5.1.3. Opportunities
  - 5.1.3.1. Potential demand from targeted therapeutics or personalized medicines
  - 5.1.3.2. Emerging adoption of pharmerging in developing economies
- 5.1.4. Challenges
  - 5.1.4.1. Concerns over IP protection and socio-politics with complex government approval process
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Pharmerging Market, by Product

6.1. Introduction
6.2. OTC Drugs
6.3. Pharmaceuticals
- 6.3.1. Branded Prescription Drugs
- 6.3.2. Generic Drugs

7. Pharmerging Market, by Indication

7.1. Introduction
7.2. Cancer & Autoimmune Diseases
7.3. Lifestyle Diseases

8. Pharmerging Market, by Distribution

8.1. Introduction
8.2. Clinics
8.3. Drug Stores
8.4. E-Commerce
8.5. Hospitals

9. Americas Pharmerging Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Pharmerging Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Pharmerging Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

Product Code: MRR-030EE4851607

LIST OF FIGURES

FIGURE 1. PHARMERGING MARKET RESEARCH PROCESS
FIGURE 2. PHARMERGING MARKET SIZE, 2022 VS 2030
FIGURE 3. PHARMERGING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PHARMERGING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 5. PHARMERGING MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
FIGURE 6. PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2022 VS 2030 (%)
FIGURE 7. PHARMERGING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 8. PHARMERGING MARKET DYNAMICS
FIGURE 9. PHARMERGING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 10. PHARMERGING MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS PHARMERGING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES PHARMERGING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC PHARMERGING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA PHARMERGING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. PHARMERGING MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 17. PHARMERGING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. PHARMERGING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. PHARMERGING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 5. PHARMERGING MARKET SIZE, BY OTC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 6. PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 7. PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PHARMERGING MARKET SIZE, BY BRANDED PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. PHARMERGING MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 11. PHARMERGING MARKET SIZE, BY CANCER & AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PHARMERGING MARKET SIZE, BY LIFESTYLE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 14. PHARMERGING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. PHARMERGING MARKET SIZE, BY DRUG STORES , BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PHARMERGING MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. PHARMERGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS PHARMERGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 31. CANADA PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. CANADA PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 33. CANADA PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 34. CANADA PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 35. MEXICO PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. MEXICO PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 37. MEXICO PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 38. MEXICO PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES PHARMERGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC PHARMERGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 49. AUSTRALIA PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. AUSTRALIA PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 53. CHINA PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. CHINA PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 55. CHINA PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 56. CHINA PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 57. INDIA PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. INDIA PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 59. INDIA PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 60. INDIA PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 61. INDONESIA PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. INDONESIA PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 65. JAPAN PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. JAPAN PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 67. JAPAN PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. JAPAN PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 69. MALAYSIA PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. MALAYSIA PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 73. PHILIPPINES PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. PHILIPPINES PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 77. SINGAPORE PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. SINGAPORE PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 81. SOUTH KOREA PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. SOUTH KOREA PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 85. TAIWAN PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. TAIWAN PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 89. THAILAND PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. THAILAND PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 91. THAILAND PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 92. THAILAND PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 93. VIETNAM PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. VIETNAM PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA PHARMERGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 102. DENMARK PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. DENMARK PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 104. DENMARK PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 105. DENMARK PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 106. EGYPT PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. EGYPT PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 108. EGYPT PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 109. EGYPT PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 110. FINLAND PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. FINLAND PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 112. FINLAND PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 113. FINLAND PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 114. FRANCE PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. FRANCE PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 116. FRANCE PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 117. FRANCE PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 118. GERMANY PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. GERMANY PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 120. GERMANY PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 121. GERMANY PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 122. ISRAEL PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. ISRAEL PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 126. ITALY PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. ITALY PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 128. ITALY PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 129. ITALY PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 130. NETHERLANDS PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. NETHERLANDS PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 134. NIGERIA PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 138. NORWAY PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. NORWAY PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 140. NORWAY PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 141. NORWAY PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 142. POLAND PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. POLAND PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 144. POLAND PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 145. POLAND PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 146. QATAR PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. QATAR PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 148. QATAR PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 149. QATAR PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 158. SOUTH AFRICA PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 162. SPAIN PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. SPAIN PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 164. SPAIN PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 165. SPAIN PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 166. SWEDEN PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. SWEDEN PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 170. SWITZERLAND PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. SWITZERLAND PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 174. TURKEY PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. TURKEY PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 176. TURKEY PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 177. TURKEY PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM PHARMERGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM PHARMERGING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM PHARMERGING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM PHARMERGING MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 186. PHARMERGING MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 187. PHARMERGING MARKET SHARE, BY KEY PLAYER, 2022
TABLE 188. PHARMERGING MARKET LICENSE & PRICING

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ